Clinical Trial Update: Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing standard neoadjuvant chemotherapy with genomics-guided chemotherapy in patients with breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED